Dermatitis Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Aseptic Skin Repair Dressing May Be a Vital Clinical Effect in Treatment of Facial Dermatitis
CONCLUSION: Aseptic skin repair dressing, employed as an adjunctive therapy for facial dermatitis, demonstrates a noteworthy capacity to effectively mitigate parameters such as patient symptom scores, facial erythema quantity, and TEWL values. Notably, the application of this dressing does not pose an elevated risk of adverse reactions. These merits substantiate the superior therapeutic efficacy of aseptic skin repair dressing in facilitating the treatment of facial dermatitis.PMID:38581327 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - April 6, 2024 Category: Complementary Medicine Authors: Wei Lu Yang Ding Xiaohua Tao Source Type: research

Real-world Experience With Upadacitinib in Adolescents and Adults With Refractory Atopic Dermatitis: A 24-week Retrospective Study
Actas Dermosifiliogr. 2024 Apr 4:S0001-7310(24)00282-5. doi: 10.1016/j.ad.2024.04.001. Online ahead of print.NO ABSTRACTPMID:38582299 | DOI:10.1016/j.ad.2024.04.001 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - April 6, 2024 Category: Dermatology Authors: J Naharro Rodr íguez E Bern á Rico F J P érez-Bootello B P érez García Source Type: research

Prenatal risk factors of indoor environment and incidence of childhood eczema in the Japan environment and children's study
In this study, we aimed to determine the indoor environmental factors that are associated with eczema in children up to 3 years of age, using national birth cohort data from the Japan Environment and Children's Study (JECS). Information on indoor environments and eczema symptoms until 3 years of age was collected using self-administered questionnaires to the mothers. A total of 71,883 and 58,639 mother-child pairs at 1.5- and 3-years-old, respectively, were included in the former analyses. To account for prenatal indoor risk factors, 17,568 (1.5-years-old) and 7063 (3-years-old) children without indoor mold and/or ETS expo...
Source: Environmental Research - April 6, 2024 Category: Environmental Health Authors: Yu Ait Bamai Chihiro Miyashita Atsuko Ikeda-Araki Keiko Yamazaki Sumitaka Kobayashi Sachiko Itoh Yasuaki Saijo Yoshiya Ito Eiji Yoshioka Yukihiro Sato Reiko Kishi Michihiro Kamijima Shin Yamazaki Yukihiro Ohya Nobuo Yaegashi Koichi Hashimoto Chisato Mori Source Type: research

Real-world Experience With Upadacitinib in Adolescents and Adults With Refractory Atopic Dermatitis: A 24-week Retrospective Study
Actas Dermosifiliogr. 2024 Apr 4:S0001-7310(24)00282-5. doi: 10.1016/j.ad.2024.04.001. Online ahead of print.NO ABSTRACTPMID:38582299 | DOI:10.1016/j.ad.2024.04.001 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - April 6, 2024 Category: Dermatology Authors: J Naharro-Rodr íguez E Bern á-Rico F J P érez-Bootello B P érez-García Source Type: research

Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study
Dupilumab, a human monoclonal antibody targeting the IL4 alpha receptor, is used for treatment of moderate to severe atopic dermatitis (AD). Previous studies have reported diagnoses of cutaneous T cell lymphoma (CTCL) after dupilumab use. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - April 6, 2024 Category: Dermatology Authors: Iraj Hasan, Lauren Parsons, Sabrina Duran, Zachary Zinn Source Type: research